Wamika Pharmaceuticals Pvt. Ltd.
About Wamika Pharmaceuticals Pvt. Ltd.
Data last updated:
Wamika Pharmaceuticals Pvt. Ltd. is a private limited company based in Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 May 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233HR2001PTC034685. Its GSTIN is 06AAACW5179K1ZX (Haryana).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹6.55 Lakh. It is led by director Naveen Kumar Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 Sharma Gardenyamuna Nagar Haryana, Haryana, India.
As per the financials filed for FY 2023, the company reported a revenue of ₹2.46 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹5.9 Lakh (net margin 2.4%) and EBITDA of ₹17.61 Lakh (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 13% over five years.
The company is associated with 1 brand: Wamika Pharmaceuticals. As per MCA filings, the company has open charges of ₹78 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address4 Sharma Gardenyamuna Nagar Haryana, Haryana, India
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Wamika Pharmaceuticals Pvt. Ltd.
Wamika Pharmaceuticals operates one associated brand: Wamika Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of generic injectables, ointment, and syrup | wamikapharma.com |
Financials of Wamika Pharmaceuticals Pvt. Ltd. FY 2025 filings available
Wamika Pharmaceuticals Pvt. Ltd. reported revenue of ₹2.46 Cr (down 6% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Wamika Pharmaceuticals Pvt. Ltd.
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 13%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wamika Pharmaceuticals Pvt. Ltd.
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹2.46 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.9 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wamika Pharmaceuticals Pvt. Ltd.
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wamika Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Wamika Pharmaceuticals Pvt. Ltd.
Wamika Pharmaceuticals has 1 current director and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Kumar Garg | Director | 23 May 2001 | 25 Years 4 Months | Current |
Auditor Details of Wamika Pharmaceuticals Pvt. Ltd.
Wamika Pharmaceuticals Pvt. Ltd. is audited by M.G. & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.G. & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Wamika Pharmaceuticals Pvt. Ltd.
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wamika Pharmaceuticals Pvt. Ltd.
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2011 | Oriental Bank of Commerce | ₹78 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Wamika Pharmaceuticals Pvt. Ltd.
Wamika Pharmaceuticals Pvt. Ltd. has 2 court cases on record: 1 filed by Wamika Pharmaceuticals, 1 filed against it. All cases are pending. Status as checked between 01 Oct 2026 and 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Yamunanagar, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Ambala, Haryana | Commercial suit | Filed against the company by Haryana State Pollution Control Board | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Wamika Pharmaceuticals Pvt. Ltd.
Employment history and EPFO contributions of people linked to Wamika Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wamika Pharmaceuticals Pvt. Ltd.
Wamika Pharmaceuticals Pvt. Ltd. has 2 board changes on record since 2001: 1 appointment and 1 cessation. The latest: Parveen Kumar Garg ceased to be Director on 11 Jan 2026.
Credit Ratings, Litigation & Regulatory Alerts for Wamika Pharmaceuticals Pvt. Ltd.
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wamika Pharmaceuticals Pvt. Ltd.
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wamika Pharmaceuticals Pvt. Ltd.
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wamika Pharmaceuticals Pvt. Ltd.
Wamika Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACW5179K1ZX | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wamika Pharmaceuticals Pvt. Ltd.
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wamika Pharmaceuticals Pvt. Ltd.
Wamika Pharmaceuticals is an active private limited company based in Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 May 2001 (25+ years old) and is registered under CIN U24233HR2001PTC034685.
Wamika Pharmaceuticals reported revenue of ₹2.46 Cr for FY 2023 (down 6% YoY).
Wamika Pharmaceuticals has 1 current director:
- Naveen Kumar Garg - Director
Wamika Pharmaceuticals reported a net profit of ₹5.9 Lakh (net margin 2.4%) and EBITDA of ₹17.61 Lakh (EBITDA margin 7.2%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wamika Pharmaceuticals is 12% over three years and 13% over five years. In the latest year (FY 2023) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wamika Pharmaceuticals is 06AAACW5179K1ZX, registered in Haryana.
The CIN (Corporate Identification Number) of Wamika Pharmaceuticals is U24233HR2001PTC034685. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wamika Pharmaceuticals has 2 court cases on record: 1 filed by the company and 1 filed against it. 2 are pending.
Wamika Pharmaceuticals was incorporated on 23 May 2001, making it 25+ years old. It is registered with the Registrar of Companies, Delhi.
Parveen Kumar Garg ceased to be Director on 11 Jan 2026. Naveen Kumar Garg was appointed as Director on 23 May 2001.